581072-15-3

Usage

Uses

Used in Pharmaceutical Synthesis:
(E)-1-[2-fluoro-6-(trifluoromethyl)phenyl]-N-hydroxymethanimine is used as a key intermediate in the synthesis of pharmaceuticals. Its unique structure, including the fluorine and trifluoromethyl groups, allows for the development of new drugs with specific properties and potential therapeutic benefits.
Used in Agrochemical Production:
In the agrochemical industry, (E)-1-[2-fluoro-6-(trifluoromethyl)phenyl]-N-hydroxymethanimine serves as an essential building block for the creation of novel agrochemicals. Its incorporation into these compounds can lead to enhanced performance and targeted effects in agricultural applications.
Used in Organic Compounds Synthesis:
(E)-1-[2-fluoro-6-(trifluoromethyl)phenyl]-N-hydroxymethanimine is also utilized in the synthesis of other organic compounds, where its fluorophenyl and trifluoromethyl groups can impart specific characteristics to the final products, making them suitable for various applications.
Used in Specialty Chemicals Production:
(E)-1-[2-fluoro-6-(trifluoromethyl)phenyl]-N-hydroxymethanimine is used as an intermediate in the production of specialty chemicals. Its presence in these chemical processes can result in the creation of materials with unique properties, useful in a wide range of industrial applications.

Upstream product

• 401-80-9 3-fluoro-trifluoromethylbenzene 
• 60611-24-7 2-fluoro-6-(trifluoromethyl)benzaldehyde 

Downstream Products

• 239087-06-0 (2-fluoro-6-(trifluoromethyl) phenyl)methanamine 
• 1150560-59-0 5-(2-fluoro-3-methoxyphenyl)-1-{[2-fluoro-6-(trifluoromethyl)phenyl]methyl}-6-methylpyrimidine-2,4(1H,3H)-dione 
• 1150560-54-5 1-{[2-fluoro-6-(trifluoromethyl)phenyl]methyl}-5-iodo-6-methylpyrimidine-2,4(1H,3H)-dione 
• 830346-47-9 1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methyl-2,4(1H,3H)-pyrimidinedione 

Relevant academic research and scientific papers

BENZISOXAZOLE COMPOUND

The present invention provides a compound, a salt thereof, or a prodrug thereof as a compound effective for preventing and/or treating fibrosis, the compound being represented by formula (1) (wherein A is an optionally substituted benzene ring; B is optionally substituted aryl or optionally substituted heteroaryl; X is an oxygen atom or a sulfur atom; Y is a nitrogen atom or a carbon atom; ------ of -----Y is a single or double bond when Y is a carbon atom, or ------ of -----Y is a single bond when Y is a nitrogen atom; each R1 independently represents lower alkyl, or two R1s may be bound to each other to form a spiro ring or a crosslinked structure, or two R1s may be bound to each other to form a saturated fused heterocycle together with nitrogen and carbon atoms constituting a ring containing Y; p is 0, 1, or 2; or (R1)p is oxo) .

PROCESSES TO PRODUCE ELAGOLIX

The present invention relates to a scalable process for the making of elagolix, its salts and the process of intermediate compounds.

[...] and its sodium salt intermediate and its salt preparation method and application (by machine translation)

The invention application [...] and its sodium salt intermediate and its salt preparation method and application, relates to medical intermediate and its preparation method and application. The present invention provides a process content provided by the

Synthesis method of key raw material compound C of Elagolix

The invention relates to a synthesis method of a key raw material compound C of Elagolix. The synthesis method comprises the following steps: performing reaction of 3-flourine-trifluorotoluene, an organic lithium reagent and DMF in the presence of TMEDA a

Oxime Carbamate-Discovery of a series of novel FAAH inhibitors

A series of novel oxime carbamates have been identified as potent inhibitors of the key regulatory enzyme of the endocannabinoid signaling system, fatty acid amide hydrolase (FAAH). In this Letter, the rationale behind the discovery and the biological evaluations of this novel class of FAAH inhibitors are presented. Both in vitro and in vivo results of selected targets are discussed, along with inhibition kinetics and molecular modeling studies.1.

AZABICYCLONONENE DERIVATIVES AS RENIN INHIBITORS

The invention relates to novel bicyclononene derivatives, related compounds and use thereof as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the